An Overview Of Side Effects Alleged By Xarelto Lawsuit Plaintiffs

March 22, 2016 – – BloodThinnerHelp.com reports on the adverse side effects alleged by plaintiffs in cases against Xarelto manufacturers, Johnson & Johnson and Bayer AG. Plaintiffs in the cases have claimed that the drug caused serious side effects about which they were not adequately warned.

The drug hit the U.S. market in 2011 when it was approved by the FDA for preventing blood clots and deep vein thrombosis in patients undergoing knee and hip replacements, suffering from atrial fibrillation, and for general use in reducing the recurrence of blood clots, and stent thrombosis in patients with acute coronary syndrome. Most lawsuits allege that the drug caused uncontrollable internal bleeding resulting in death or serious injury but other allegations regarding the side effects of the blood thinner have been brought to court as well. Injuries alleged by plaintiffs include stroke, heart attack, rectal bleeding, gastrointestinal bleeding, epidural hematoma, pulmonary embolism and brain hemorrhages.

Due to the increasing number of cases alleging such side effects, Xarelto cases have been consolidated for more effective processing. A multidistrict litigation panel (MDL No. 2592) was created in New Orleans, Louisiana for cases filed federally. Almost 3,000 cases have now been filed. A mass tort program was also created in Pennsylvania for those cases filed within the commonwealth. That number has now reached 620 cases. Bellwether trials for cases consolidated in the MDL will be presided over by Judge Eldon E. Fallon.They are expected to begin in February 2017 after a total of 40 cases have been selected randomly and by the plaintiffs and the defense.

As those cases alleging adverse side effects approach bellwether trials, Attorney Joseph Osborne is working to ensure that those who have taken the drug and believe they have suffered serious side effects have the opportunity to explore their legal rights fully. Qualifying individuals may be entitled to substantial financial compensation and legal action. Osborne is currently offering complimentary legal consultations for affected individuals.

For more information on Xarelto, or to ask questions, contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008804